Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Weight Loss × Ibuprofen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Pain 3 Cachexia 3 Breast Neoplasms 3 Trigger Finger Disorder 2 Prostatic Neoplasms 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Inflammation 2 Ganglion Cysts 2 De Quervain Disease 2 Colorectal Neoplasms 2 Weight Loss 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Supratentorial Brain Tumor 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatitis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Pituitary Neoplasms 1 Patient Satisfaction 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Nose Neoplasms 1 Neoplasm Metastasis 1 Mucositis 1 Menorrhagia 1

Interventions

Exercise 10 Diet 6 Caloric Restriction 5 Nutrition Assessment 4 Metformin 4 Octreotide 3 Megestrol Acetate 3 Cognitive Behavioral Therapy 3 anamorelin 2 Standard of Care 2 Olanzapine 2 Mirtazapine 2 Melatonin 2 Liraglutide 2 Eicosapentaenoic Acid 2 Diet, Carbohydrate-Restricted 2 Diet Therapy 2 sibutramine 1 remune 1 olanzapine-fluoxetine combination 1 lime 1 irinotecan sucrosofate 1 bermekimab 1 Weight Reduction Programs 1 Urine Specimen Collection 1 Tirzepatide 1 TOPS 1 Surveys and Questionnaires 1 Sugars 1 Sampling Studies 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00625742 2016-02-12

Multimodal Treatment Strategy for Cancer Cachexia

M.D. Anderson Cancer Center

Phase NA Terminated

15 enrolled 4 charts

Cachexia, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡